EMA appoints head of legal
July 19, 2013The European Medicines Agency has appointed Stefano Marino as head of Legal Service.An Italian national, Marino holds a law degree …
Havas Lynx launches med ed agency
July 19, 2013Medical Communications HAVAS LYNX, medical
The healthcare communications group Havas Lynx has created a new medical education and scientific exchange agency called Havas Lynx Medical. …
Funding boost for lung cancer ‘map’
July 18, 2013Research and Development, Sales and Marketing cancer research, lung cancer, tracerx
A new Cancer Research UK study aims to unlock lung cancer’s secrets by tracking how lung tumours develop and evolve …
GSK finance director barred from leaving China
July 18, 2013Medical Communications, Sales and Marketing GSK, bribes, corruption, hong
GlaxoSmithKline’s finance director and British citizen Steve Nechelput has been stopped from the leaving China as the bribery case into …
Tissue Regenix appoints Sanofi VP
July 18, 2013Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing couldwell, tissue regenix
Medical devices firm Tissue Regenix has appointed Steven Couldwell as a non-executive director. With over 14 years of senior management …
Marginal sales increase for Abbott
July 18, 2013Sales and Marketing AbbVie, Abbott, Q2
Abbott’s second quarter results saw the company buffeted by currency exchange issues – primarily the yen weakening against the US …
Nexium gets its own promotional YouTube channel
July 17, 2013Medical Communications AstraZeneca, Nexium, reflux, youtube
AstraZeneca’s once biggest selling drug Nexium has been given its own YouTube channel in the hope of shoring up sales …
J&J sees Q2 sales rise
July 17, 2013Sales and Marketing Elan, J&J, JJ, Q2, Synthes, sales
Johnson & Johnson saw overall sales rise 8.5% year-on-year in the second quarter of 2013, with the US healthcare group …
Lundbeck/Otsuka Alzheimer’s drug improves cognition
July 17, 2013Research and Development, Sales and Marketing Alzheimer's, Lundbeck, Otsuka
Lundbeck and partner Otsuka have posted positive Phase II results for their experimental Alzheimer’s drug. The latest data show statistically …
Mitsubishi buys into tobacco production firm Medicago
July 17, 2013Manufacturing and Production Mitsubishi, Phillip Morris, medicago, tobacco
Mitsubishi Tanabe Pharma has bought a majority stake in Canada’s Medicago, a company which specialises in manufacturing vaccines in tobacco …
Eleven hospitals put on notice
July 17, 2013Sales and Marketing Hunt, Labour, Mid Staffs, NHS, burnham, keogh
There were angry exchanges in the House of Commons yesterday as health secretary Jeremy Hunt announced that 11 hospitals in …
WinchPharma appoints new chief executive
July 17, 2013Manufacturing and Production, Research and Development, Sales and Marketing lyndon nicholson, winchpharma
Healthcare products firm WinchPharma has appointed Lyndon Nicholson as its new chief executive with immediate effect. Nicholson will replace former …
Dementia rates declining in UK
July 17, 2013Research and Development, Sales and Marketing Alzheimer's, UK, brain, dementia
A new study has found that the rate of dementia in Britain has decreased over the past two decades, contrary …
GSK exec admits bribery on live TV
July 16, 2013Medical Communications, Sales and Marketing China, GSK, bribery, cctv
A senior member of GSK China has appeared on state television admitting the firm’s guilt in the ongoing bribery allegations. …
Ipsen buys Syntaxin
July 16, 2013Research and Development, Sales and Marketing R&D, ipsen, neurology, syntaxin, tsi
French pharma group Ipsen has snapped up privately-owned UK life sciences firm Syntaxin for an upfront payment of €28 million …
Roche ‘considers’ Alexion bid
July 16, 2013Research and Development, Sales and Marketing Alexion, Orphan, Roche, soliris
Speculation that Roche is considering a bid for rare disease specialist Alexion Pharmaceuticals has unleashed a flurry of comment – …
The pharma industry in the public imagination
July 16, 2013Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Ben Adams, image, literary, pharma
Popular culture in both films and literature depict pharma and scientists as part of a nefarious industry, hell bent on …
NICE rejects Pfizer blood cancer drug
July 16, 2013Sales and Marketing BMS, CML, NICE, Pfizer, bosulif
NICE is not recommending Pfizer’s blood cancer drug Bosulif due to uncertainties over its cost effectiveness and survival benefit. In …
Aesica appoints two new business development managers
July 16, 2013Manufacturing and Production, Research and Development, Sales and Marketing Aesica, ross, thomas
Contract development and manufacturing organisation Aesica has appointed Sven Thomas and David Ross as business development managers. Under the new …
Irish eyes smiling as Pfizer plans $130m investment
July 15, 2013Manufacturing and Production IDA, Pfizer, cork, grange
The company has said it will spend $100m upgrading its Grange Castle site in Dublin and $30m at Ringaskiddy in …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
